Loss of metabotropic glutamate receptor 2 escalates alcohol consumption
Identification of genes influencing complex traits is hampered by genetic heterogeneity, the modest effect size of many alleles, and the likely involvement of rare and uncommon alleles. Etiologic complexity can be simplified in model organisms. By genomic sequencing, linkage analysis, and functional...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 110; no. 42; pp. 16963 - 16968 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
15.10.2013
NATIONAL ACADEMY OF SCIENCES National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Identification of genes influencing complex traits is hampered by genetic heterogeneity, the modest effect size of many alleles, and the likely involvement of rare and uncommon alleles. Etiologic complexity can be simplified in model organisms. By genomic sequencing, linkage analysis, and functional validation, we identified that genetic variation of Grm2 , which encodes metabotropic glutamate receptor 2 (mGluR2), alters alcohol preference in animal models. Selectively bred alcohol-preferring (P) rats are homozygous for a Grm2 stop codon (Grm2 *407) that leads to largely uncompensated loss of mGluR2. mGluR2 receptor expression was absent, synaptic glutamate transmission was impaired, and expression of genes involved in synaptic function was altered. Grm2 *407 was linked to increased alcohol consumption and preference in F2 rats generated by intercrossing inbred P and nonpreferring rats. Pharmacologic blockade of mGluR2 escalated alcohol self-administration in Wistar rats, the parental strain of P and nonpreferring rats. The causal role of mGluR2 in altered alcohol preference was further supported by elevated alcohol consumption in Grm2 ⁻/⁻ mice. Together, these data point to mGluR2 as an origin of alcohol preference and a potential therapeutic target. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1309839110 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Author contributions: Z.Z., D.M.L., H.J.E., M.H., and D.G. designed research; Z.Z., C.K., T.L., W.X., M.K., J.D.T., E.B., A.F., M.F., and E.A. performed research; Z.Z., C.K., T.L., W.X., M.K., J.D.T., Q.Y., M.-A.E., C.A.H., P.-H.S., D.M.L., H.J.E., M.H., and D.G. analyzed data; and Z.Z., M.H., and D.G. wrote the paper. Edited by Floyd Bloom, The Scripps Research Institute, La Jolla, CA, and approved September 5, 2013 (received for review May 24, 2013) |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1309839110 |